Kidney failure risk after intensive care studied

Kidney failure was the outcome tracked in a study of adults who survived intensive care after acute kidney injury. Researchers examined data from 2012 to 2022 for 30,498 adults treated at a major United States academic medical centre. All of the patients had kidney injury while in intensive care and survived to hospital discharge. The team followed them for up to two years using hospital electronic health records and the United States Renal Data System. The findings were presented at ASN Kidney Week 2026, held October 22 to 25.

During follow up, 2,723 patients, or 9 percent, died and 326 patients, or 1 percent, developed end stage kidney disease. The study looked at individual and neighbourhood level social determinants of health. Those factors are the conditions in which people live and work, and the study tested whether they were linked to kidney failure after discharge. The results point to gaps that remain after a patient leaves intensive care, even when the immediate illness has passed.

After adjustment for other factors, Black race was linked to a 43 percent higher risk of kidney failure compared with white race. Having health insurance coverage was linked to a 40 percent lower risk. Neighbourhood level socioeconomic disadvantage was also linked to a higher risk on its own. Higher risks were seen among residents of moderately deprived neighbourhoods and highly deprived neighbourhoods. The authors did not present the findings as proof that any single factor caused kidney failure. They presented them as links found in the records studied.

Kidney failure after intensive care

Kidney injury in intensive care is a sudden drop in kidney function during serious illness. Many patients recover enough to leave hospital, but the study shows that risk does not end at discharge. Follow up in the study lasted up to two years, which gave researchers time to see later kidney failure and deaths recorded in health records and the national renal data system. For survivors, that period after discharge is when regular checks, repeat lab tests and access to follow up care can matter.

The study was based on records from one major academic medical centre, so the results describe that patient group and the years covered. They do not by themselves describe every hospital or every patient group in the United States.

Kidney failure and social determinants of health

Social factors were central to the design of the study. The researchers examined both individual factors, such as insurance coverage, and neighbourhood factors, such as socioeconomic disadvantage. Insurance coverage may affect whether a patient can attend follow up appointments, fill prescriptions and return for tests after discharge. Neighbourhood disadvantage may affect transport, food access, housing stability and access to local clinics. The study did not measure each of those paths separately, so it cannot say which path mattered most for any one patient.

First author Dilaram Acharya, of the University of Alabama at Birmingham, said standardized assessment of social determinants of health in clinical practice may improve risk stratification for kidney failure. Acharya said such assessment may also help identify acute kidney injury survivors most likely to benefit from post discharge interventions. Corresponding senior author Javier Neyra, also of the University of Alabama at Birmingham, said implementation studies of best practices to promote kidney health in vulnerable populations are needed. Both statements describe next steps for research and practice, rather than a treatment already proven to work.

Kidney failure follow up after critical illness

Critical illness leaves many survivors with needs that go beyond the original hospital stay. Kidney function is one of those needs, because acute kidney injury can leave lasting damage even when a patient feels better at discharge. The study findings suggest that a standard check of social factors at discharge could help clinicians decide who needs closer monitoring. That could mean earlier referral or more frequent lab checks.

The findings were presented at ASN Kidney Week 2026, a meeting of kidney specialists. Presentation at a conference is a step before full peer review in many cases, and readers should note that the study as presented draws on records through 2022. The authors called for studies that test best practices in real clinics, so that any change in follow up care rests on tested results rather than on links found in past records alone. For now, the concrete result is clear: among 30,498 survivors studied, 326 developed end stage kidney disease, and insurance and neighbourhood disadvantage were linked to that risk in opposite directions.